Optimizing Outcomes in Older Patients With HBV

Read my take on why it is important to identify, monitor, and treat older patients with HBV to avoid downstream consequences.

Nancy Reau, MD Released: October 11, 2022

When managing older patients with chronic hepatitis B, the first question should be, “What else is going on in their life and how will that affect the approach to disease management?”

Graham R. Foster, FRCP, PhD Released: November 18, 2022

Older age is more of a state of mind than a biological definition. We should be proactive in monitoring and treating all patients with CHB, regardless of age.

George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA) Released: December 1, 2022

Read expert faculty member summaries of key data in older patients with HBV, including HBV and HDV epidemiology, treatment criteria, risk of liver complications, the influence of comorbidities on treatment decisions, and treatment considerations for HBV and HDV.

Graham R. Foster, FRCP, PhD Nancy Reau, MD Released: November 16, 2022

Listen to expert insights on the management of HBV in older adults, including epidemiology of HBV and HDV in this population, treatment criteria, risk of liver-related complications, comorbidity considerations, and treatment and monitoring strategies.

Graham R. Foster, FRCP, PhD Released: January 17, 2023

How do you define and evaluate an older patient who is living with chronic HBV infection? Listen as Nancy Reau, MD, discusses strategies and considerations for managing older patients with HBV.

Nancy Reau, MD Released: October 10, 2022

How do comorbidities and medication adherence affect treatment of older adults with HBV? Listen as Graham R. Foster, FRCP, PhD, discusses these and other issues in HBV management.

Graham R. Foster, FRCP, PhD Released: October 27, 2022

Older age is more a state of mind than a biological definition. We should be proactive in monitoring and treating all patients with chronic hepatitis B, regardless of age. Listen as Dr George Lau discusses these and other issues in HBV management.

George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA) Released: December 15, 2022